Glen Rock, NJ, United States of America

Maggie Focht

This inventor holds 1 USPTO granted patent. Top assignee: Nymox Pharmaceutical Corporation. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maggie Focht. Retrieved from https://idiyas.com/inventor/maggie-focht

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Maggie Focht

Introduction

Maggie Focht is a notable inventor based in Glen Rock, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the area of neural thread protein. Her work has implications for both diagnostic and therapeutic methods.

Latest Patents

Maggie holds 1 patent for her invention titled "Preferred segments of neural thread protein." This invention focuses on preferred repeat sequences of Neural Thread Protein (NTP), including peptides, mimetics, antibodies, and nucleic acids derived from these sequences. The patent outlines various diagnostic and therapeutic methods utilizing these preferred NTP sequences.

Career Highlights

Maggie is currently associated with Nymox Pharmaceutical Corporation, where she continues to advance her research and innovations. Her work at Nymox has positioned her as a key player in the development of new therapeutic approaches.

Collaborations

Maggie collaborates with esteemed colleagues, including Judith Fitzpatrick and Paul A Averback, who contribute to her research endeavors and help drive innovation within the company.

Conclusion

Maggie Focht's contributions to the field of biotechnology through her patent on neural thread protein highlight her innovative spirit and dedication to advancing medical science. Her work continues to pave the way for new therapeutic possibilities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…